Reuters botches article on ivermectin and omicron

Look for that machine to roar once more, perhaps by claiming that Reuters had it right the first time. Early Tuesday morning, host Mike Dinow of One America News (OAN) told viewers: “A top Japanese drugmaker confirms ivermectin is highly efficient in fighting covid-19 and the omicron strain. According to Nagoya-based Kowa Co., phase III clinical trials have confirmed ivermectin has a strong antiviral effect in human beings, in human patients.” The finding, said Dinow, “further disproves mainstream media attacks on ivermectin.”